Evidence map›Paper›PMID 38769992›Full record

ArticleFrontiers in nutrition2024

Designing an effective dissolution test for bilayer tablets tailored for optimal melatonin release in sleep disorder management.

Rebecca Bassetto, Emanuele Amadio, Francesco Ciampanelli, Stefano Perin, Pietro Ilari, Paolo Gaballo, Martina Callegari, Sara Feltrin, Jacopo Gobbo, Samuele Zanatta and 1 more

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rebecca BassettoLabomar SpA, Treviso, Italy.
Emanuele AmadioLabomar SpA, Treviso, Italy.
Francesco CiampanelliLabomar SpA, Treviso, Italy.
Stefano PerinLabomar SpA, Treviso, Italy.
Pietro IlariLabomar SpA, Treviso, Italy.
Paolo GaballoLabomar SpA, Treviso, Italy.
Martina CallegariLabomar SpA, Treviso, Italy.
Sara FeltrinLabomar SpA, Treviso, Italy.
Jacopo GobboLabomar SpA, Treviso, Italy.
Samuele ZanattaLabomar SpA, Treviso, Italy.
Walter BertinLabomar SpA, Treviso, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This project aims to investigate the release performance of bilayer tablet (BL-Tablet) designed with both fast and slow-release technology, targeting sleep disorders. The tablet incorporates Melatonin, extracts of

Indexed as

bioaccessibilitybiorelevant mediadissolutionmelatoninmodulated releaseSIFC system

Identifiers

PMID38769992
PMCPMC11102985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.